PNC Financial Services Group’s MaxCyte MXCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12.2K Buy
17,311
+9,606
+125% +$8.97K ﹤0.01% 3883
2025
Q4
$11.9K Buy
7,705
+24
+0.3% +$38 ﹤0.01% 3878
2025
Q3
$12.1K Buy
7,681
+441
+6% +$766 ﹤0.01% 3858
2025
Q2
$15.8K Sell
7,240
-17,564
-71% -$42.5K ﹤0.01% 3679
2025
Q1
$67.7K Buy
24,804
+688
+3% +$2.71K ﹤0.01% 2918
2024
Q4
$100K Sell
24,116
-72
-0.3% -$272 ﹤0.01% 2675
2024
Q3
$94.1K Buy
24,188
+4,901
+25% +$20.6K ﹤0.01% 2702
2024
Q2
$75.6K Buy
19,287
+13,032
+208% +$56.1K ﹤0.01% 2799
2024
Q1
$26.2K Hold
6,255
﹤0.01% 3303
2023
Q4
$29.4K Buy
+6,255
New +$24.4K ﹤0.01% 3227

Other funds holding MXCT

PNC Financial Services Group's MXCT Position: Q1 2026 in Review

PNC Financial Services Group increased its MaxCyte (MXCT) stake by 125% in Q1 2026, buying an estimated $8.97K and bringing the position to 17,311 shares worth $12.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3883.

PNC Financial Services Group first reported a position in MXCT in Q4 2023 and has held it in 10 quarters since. The position peaked at $100K in Q4 2024. 130 funds tracked by Wall St. Rank hold MXCT as of Q1 2026.

  • PNC Financial Services Group held 17,311 shares of MaxCyte worth $12.2K as of Q1 2026.
  • PNC Financial Services Group bought 9,606 MaxCyte shares in Q1 2026, an estimated $8.97K.
  • MaxCyte made up ﹤0.01% of PNC Financial Services Group's portfolio in Q1 2026, its #3883 holding.
  • PNC Financial Services Group first reported a position in MaxCyte in Q4 2023 and has held it in 10 quarters since.
  • PNC Financial Services Group's MaxCyte position peaked at $100K in Q4 2024.
  • 130 funds tracked by Wall St. Rank held MaxCyte as of Q1 2026.

Based on PNC Financial Services Group's 13F filing for Q1 2026, filed 8 May 2026.